Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Surg.

Sec. Surgical Oncology

Comparison of the application value of bipolar electrocoagulation and ultrasonic scalpel in robot-assisted thyroid carcinoma surgery: A single-center study based on perioperative indicator and short-term prognosis

Provisionally accepted
  • 1Research Institute of General Surgery, Jinling Hospital affiliated to Medical School of Nanjing University, 305 Zhongshan East Road, Xuanwu District, Nanjing 210002, PR, China
  • 2Research Institute of General Surgery, Jinling Hospital affiliated to Medical School of Nanjing University, 305 Zhongshan East Road, Xuanwu District,, Nanjing 210002, PR, China

The final, formatted version of the article will be published soon.

Objective To study the effectiveness of bipolar electrocoagulation cutting technology and traditional ultrasonic scalpel cutting technology in Da Vinci robot-assisted thyroid carcinoma surgery. Methods We retrospectively reviewed 154 patients with thyroid carcinoma who had undergone ultrasonic scalper (US, n=81) or Maryland bipolar electrocoagulation (MB, n=73) cutting in Da Vinci robotic surgery. The operation time, complications, efficacy and other clinical indicators were compared between the two groups. Results The operation time of the MB group was significantly reduced(p<0.05),and the drainage volume was significantly higher than that of the US group(p<0.05). The postoperative PTH and serum calcium levels of total thyroidectomy in the MB group were higher than those in the US group (p<0.05), which were (US: 2.07±1.51, MB: 2.42±1.46) and (US: 2.15±0.14, MB: 2.20±0.13). Conclusion Bipolar coagulation cutting technology is more precise. Its application in robotic thyroid surgery can significantly shorten the operation time and protect parathyroid function, which has better clinical application prospects.

Keywords: Bipolar Electrocoagulation technique, da Vinci robotic surgery, Postoperative Complications, Short-term prognosis, Thyroid carcinoma

Received: 10 Dec 2025; Accepted: 20 Jan 2026.

Copyright: © 2026 Dong, Huo, Wang, Gu and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Jun Gu
Xiaofan Xu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.